RadNet Operating Income 2010-2025 | RDNT

RadNet operating income from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
RadNet Annual Operating Income
(Millions of US $)
2024 $105
2023 $99
2022 $46
2021 $83
2020 $36
2019 $70
2018 $31
2017 $50
2016 $38
2015 $39
2014 $53
2013 $44
2012 $45
2011 $51
2010 $42
2009 $42
RadNet Quarterly Operating Income
(Millions of US $)
2025-03-31 $-24
2024-12-31 $25
2024-09-30 $34
2024-06-30 $35
2024-03-31 $11
2023-12-31 $24
2023-09-30 $43
2023-06-30 $24
2023-03-31 $7
2022-12-31 $22
2022-09-30 $7
2022-06-30 $20
2022-03-31 $-2
2021-12-31 $5
2021-09-30 $33
2021-06-30 $28
2021-03-31 $18
2020-12-31 $21
2020-09-30 $23
2020-06-30 $0
2020-03-31 $-9
2019-12-31 $24
2019-09-30 $17
2019-06-30 $22
2019-03-31 $7
2018-12-31 $-1
2018-09-30 $16
2018-06-30 $16
2018-03-31 $-1
2017-12-31 $18
2017-09-30 $11
2017-06-30 $14
2017-03-31 $7
2016-12-31 $15
2016-09-30 $12
2016-06-30 $8
2016-03-31 $3
2015-12-31 $10
2015-09-30 $17
2015-06-30 $13
2015-03-31 $-2
2014-12-31 $15
2014-09-30 $15
2014-06-30 $16
2014-03-31 $8
2013-12-31 $14
2013-09-30 $9
2013-06-30 $13
2013-03-31 $8
2012-12-31 $7
2012-09-30 $14
2012-06-30 $13
2012-03-31 $11
2011-12-31 $16
2011-09-30 $11
2011-06-30 $15
2011-03-31 $9
2010-12-31 $16
2010-09-30 $11
2010-06-30 $10
2010-03-31 $4
2009-12-31 $14
2009-09-30 $9
2009-06-30 $9
2009-03-31 $10
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.157B $1.830B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.118B 20.03
Encompass Health (EHC) United States $12.188B 25.75
DaVita (DVA) United States $10.277B 14.63
Chemed (CHE) United States $8.063B 25.40
Elanco Animal Health (ELAN) United States $6.859B 14.88
Option Care Health (OPCH) United States $5.174B 23.23
Amedisys (AMED) United States $3.189B 21.49
Addus HomeCare (ADUS) United States $2.075B 23.12
LifeStance Health (LFST) United States $2.045B 0.00
Astrana Health (ASTH) United States $1.444B 34.64
U.S Physical Therapy (USPH) United States $1.170B 30.33
Aveanna Healthcare Holdings (AVAH) United States $0.958B 54.67
Pennant (PNTG) United States $0.954B 36.05
Atai Life Sciences (ATAI) Germany $0.423B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.044B 0.00
Daxor (DXR) United States $0.042B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00